Literature DB >> 8105126

Central alpha 2-adrenoceptor-mediated inhibition of gastric motility in rats.

M Nagata1, Y Osumi.   

Abstract

We investigated the subtype of alpha-adrenoceptors participating in central noradrenergic inhibition of gastric motility in urethane-anesthetized rats. Noradrenaline at 10 nmole administered intracisternally (i.c.) significantly decreased gastric motility. Yohimbine at 10 nmole, i.c., but not the same dose of prazosin, abolished this noradrenaline-induced decrease in gastric motility. Clonidine at 10 nmole, i.c., but not phenylephrine at 20 nmole, significantly decreased gastric motility. These results suggest that alpha 2-adrenoceptor-mediated mechanisms in the brain stem are involved in noradrenergic inhibitory regulation of gastric motility.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8105126     DOI: 10.1254/jjp.62.329

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  5 in total

1.  Central neural responses to restraint stress are altered in rats with an early life history of repeated brief maternal separation.

Authors:  L Banihashemi; E J O'Neill; L Rinaman
Journal:  Neuroscience       Date:  2011-06-26       Impact factor: 3.590

2.  Clonidine inhibits postprandial response of antral myoelectrical activity.

Authors:  L W Qian; L J Peters; J D Chen
Journal:  Dig Dis Sci       Date:  2001-03       Impact factor: 3.199

3.  Dual Alpha2C/5HT1A Receptor Agonist Allyphenyline Induces Gastroprotection and Inhibits Fundic and Colonic Contractility.

Authors:  Zoltán S Zádori; Ágnes Fehér; Viktória E Tóth; Mahmoud Al-Khrasani; László Köles; Szabina Sipos; Fabio Del Bello; Maria Pigini; Klára Gyires
Journal:  Dig Dis Sci       Date:  2016-02-10       Impact factor: 3.199

Review 4.  Central serotonergic and noradrenergic receptors in functional dyspepsia.

Authors:  S O'Mahony; T G Dinan; P W Keeling; A S B Chua
Journal:  World J Gastroenterol       Date:  2006-05-07       Impact factor: 5.742

5.  Abnormal gastric myoelectrical activity in postural tachycardia syndrome.

Authors:  William H Seligman; David A Low; Masato Asahina; Christopher J Mathias
Journal:  Clin Auton Res       Date:  2012-12-02       Impact factor: 4.435

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.